Qube Research & Technologies (QRT)’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.5K Buy
+11,160
New +$75.3K ﹤0.01% 3073
2025
Q3
Sell
-14,910
Closed -$134K 3965
2025
Q2
$134K Buy
+14,910
New +$88.4K ﹤0.01% 2987
2024
Q3
Sell
-2,174
Closed -$23.1K 4144
2024
Q2
$23.1K Sell
2,174
-24,100
-92% -$257K ﹤0.01% 2861
2024
Q1
$231K Buy
26,274
+1,835
+8% +$14.9K ﹤0.01% 2953
2023
Q4
$167K Buy
24,439
+22,231
+1,007% +$182K ﹤0.01% 2889
2023
Q3
$21.6K Buy
+2,208
New +$17.7K ﹤0.01% 3133
2020
Q2
Sell
-15,600
Closed -$81K 2004
2020
Q1
$81K Hold
15,600
﹤0.01% 988
2019
Q4
$115K Buy
+15,600
New +$129K ﹤0.01% 1447

Other funds holding ULBI

Qube Research & Technologies (QRT)'s ULBI Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Ultralife (ULBI) in Q2 2026: 11,160 shares worth $70.5K. The stake represents ﹤0.01% of the portfolio and ranks #3073 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ULBI as recently as Q2 2025.

Qube Research & Technologies (QRT) first reported a position in ULBI in Q4 2019 and has held it in 8 quarters since. The position peaked at $231K in Q1 2024. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • Qube Research & Technologies (QRT) held 11,160 shares of Ultralife worth $70.5K as of Q2 2026.
  • Ultralife was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Ultralife made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3073 holding.
  • Qube Research & Technologies (QRT) first reported a position in Ultralife in Q4 2019 and has held it in 8 quarters since.
  • Qube Research & Technologies (QRT)'s Ultralife position peaked at $231K in Q1 2024.
  • 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.